Text Size
1 study found for:    GIST | Open Studies | Mexico

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer;   Advanced Breast Cancer;   Advanced Gastric Cancer;   Advanced/Metastatic Non-small Cell Lung Cancer;   Gastrointestinal Stromal Tumor;   Hepatocellular Carcinoma;   Metastatic Castration-resistant Prostate Cancer;   Metastatic Renal Cell Cancer;   Non Small Cell Lung Cancer;   Pancreatic Islet Cell Carcinoma;   Pancreatic Neuroendocrine Tumor;   Thyroid Cancer
Intervention: Drug: sunitinib
To Top

† Indicates status has not been verified in more than two years